Effects of Aerobic Exercise on Microalbuminuria and Enzymuria in Type 2 Diabetic Patients

REFERENCES

• Viberti GC, Walker JD, Pinto J. Diabetic nephropathy. International Textbook of Diabetes Mellitus, KGMM Alberti, RA DeFronzo, H Keen. Wiley, Chichester, New York 1992; 1267–1328
   Google Scholar
• Verho M, Farber G, Heinen B, Grotsch H. The excretion of renal enzymes during rest and exercise: a double blind comparison between placebo and penbutolol. Int J Clin Pharmacol Res. 1987; 7: 27–32
   Google Scholar
• Houser MT. Characterization of recumbent, ambulatory, and postexercise proteinuria in the adolescent. Pediatr Res. 1987; 21(5)442–446
   Google Scholar
• Stefanovic V, Antic S. Plasma cell membrane glycoprotein 1 (PC-1): a marker of insulin resistance in obesity, uremia, and diabetes mellitus. Clin Lab. 2004; 50: 271–278
   PubMedGoogle Scholar
• Stefanovic V, Antic S, Mitic-Zlatkovic M, Vlahovic P. Reversal of lymphocyte PC-1 activity in patients with type 2 diabetes treated with metformin. Diabetes Metab Res Rev. 1999; 15: 400–405
   PubMed Web of Science ®Google Scholar
• Stefanovic V, Vlahovic P, Ardaillou N, Ronco P, Ardaillou R. Cell surface aminopeptidase A and N activities in human glomerular epithelial cells. Kidney Int. 1992; 41: 1571–1580
   PubMed Web of Science ®Google Scholar
• Dixon J, Kaklamanis L, Turley H, et al. Expression of aminopeptidase-N (CD 13) in normal tissues and malignant neoplasms of epithelial and lymphoid origin. J Clin Pathol. 1994; 47: 43–47
   PubMed Web of Science ®Google Scholar
• Stefanovic V, Vlahovic P, Ardaillou N, Ronco P, Nivez MP, Ardaillou R. Characterization and control of expression of cell surface aminopeptidase N activity in human mesangial glomerular cells. Cell Physiol Biochem. 1992; 2: 57–68
   Google Scholar
• Lazarevic G, Antic S, Cvetkovic T, Vlahovic P, Tasic I, Stefanovic V. Physical activity programme and its effects on insulin resistance and oxidative defense in obese male patients with Type 2 diabetes mellitus. Diabetes Metab. 2006; 32: 583–590
   Google Scholar
• Pereira MA, FitzGerald SJ, Gregg EW, et al. A collection of physical activity questionnaires for health-related research. Med Sci Sports Exerc. 1997; 29(Suppl)S33–S35
   Google Scholar
• Horak E, Hopfer SM, Sunderman W. Spectrophotometric assay for urinary N-acetyl-β-D-glucosaminidase activity. Clin Chem. 1981; 27: 1180–1185
   PubMed Web of Science ®Google Scholar
• Haugen HF, Skrede S. Nucleotide pyrophosphatase and phosphodiesterase I. Organ distribution and activities in body fluids. Clin Chem. 1977; 23: 1531–1537
   PubMedGoogle Scholar
• Mathews DR, Horsker JP, Rudeniski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28: 412–419
   PubMed Web of Science ®Google Scholar
• Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge. Clin Chem. 1972; 18: 499–502
   PubMed Web of Science ®Google Scholar
• De Backer G, Ambrosioni E, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J. 2003; 24: 1601–1610
   PubMed Web of Science ®Google Scholar
• Koroljuk AM, Ivanova IL, Majorova GI, Tokarev IB. Metod opredeljenja aktivnosti katalazi. Lab Delo. 1988; 1: 16–18
   Google Scholar
• Beutler E, Duron O, Kelly MB. Improved method for the determination of blood glutathione. J Lab Clin Med. 1963; 61: 882–888
   PubMed Web of Science ®Google Scholar
• Ellman LG. Tissue sulphydryl groups. Arch Biochem Biophys. 1959; 82: 70–77
   PubMed Web of Science ®Google Scholar
• Andreeva IL, Kozemjakin AL, Kiskun AA. Modifikacija metoda opredelenia perekisej lipidov v teste s tiobarbiturovoj kislotoj. Lab Delo. 1988; 11: 41–43
   PubMedGoogle Scholar
• Jain SK, Levine NS, Duett J, Hollier B. Elevated lipid peroxidation levels in red blood cells of streptozotocin-treated diabetic rats. Metabolism. 1990; 39: 971–975
   PubMed Web of Science ®Google Scholar
• Valmadrid C, Klein R, Moss S, Klein B. The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older onset diabetes mellitus. Arch Intern Med. 2000; 160: 1093–1100
   PubMed Web of Science ®Google Scholar
• Fredrickson S, Ferro T, Schutrumpf A. Disappearance of microalbuminuria in a patient with type 2 diabetes and the metabolic syndrome in the setting of an intense exercise and dietary program with sustained weight reduction. Diabetes Care. 2004; 27: 1754–1755
   PubMedGoogle Scholar
• Adedapo KS, Abbiyesuku FM, Adedapo AD, Osotimehin BO. Microalbuminuria in controlled type 2 diabetes mellitus patients. Afr J Med Sci. 2001; 30: 323–326
   Google Scholar
• Mocan Z, Erem C, Yildirim M, Telatar M, Deger C. Urinary β2-microglobulin levels and urinary N-acetyl-β-D-glucosaminidase enzyme activities in early diagnosis of non-insulin dependent diabetes mellitus nephropathy. Diabetes Res. 1994; 26: 101–107
   PubMedGoogle Scholar
• Stefanovic V, Antic S, Mitic-Zlatkovic M, et al. Urinary PC-1 and N-acetyl-β-D-glucosaminidase activity in patients with type 2 diabetes treated with metformin, gliclazide or glibenclamide. Ann Clin Biochem. 2003; 40: 232–234
   Google Scholar
• Watanabe Y, Nunoi K, Nakamura Y, Fujishima M. Contribution of glycaemic control to the levels of urinary N-acetyl-β-D-glucosaminidase (NAG), total protein, β2-microglobulin andserum NAG in type 1 (insulin-dependent) diabetes mellitus without micralbuminuria. Clin Nephrol. 1987; 28: 227–231
   Google Scholar
• Shimojo N, Kitahashi S, Naka K, et al. Comparison of N-acetyl-beta-D-glucosaminidase and alanine animopeptidase activities for evaluation of microangiopathy in diabetes mellitus. Metabolism. 1987; 36: 277–280
   Google Scholar